Molecular and Biochemical Characterization of Peripheral Blood MMP-2 Upregulation and TIMP-2 Downregulation in In-Stent Restenosis
Scindeks Assistant SCIndeks Assistant: Journal Management System
PDF

How to Cite

1.
Zhou X, Ma H, Qiao X, Bai M. Molecular and Biochemical Characterization of Peripheral Blood MMP-2 Upregulation and TIMP-2 Downregulation in In-Stent Restenosis. J Med Biochem [Internet]. 2026 Jul. 9 [cited 2026 Jul. 12];. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/67085

Abstract

Background: The matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 (MMP-2/TIMP-2) axis is an important regulator of extracellular matrix turnover and vascular remodeling. Most previous studies have focused on either circulating protein levels or mRNA expression alone. Because PBMC mRNA expression and plasma protein concentration reflect different regulatory levels, paired cross-level analysis may provide a more complete characterization of peripheral blood MMP-2/TIMP-2 alterations in ISR. This study investigated the molecular and biochemical dysregulation of the peripheral blood MMP-2/TIMP-2 axis in patients with ISR.

Methods: A total of 117 patients who underwent follow-up evaluation 6–12 months after coronary stent implantation were included, comprising 42 patients with ISR and 75 without ISR. Plasma MMP-2 and TIMP-2 concentrations were measured by ELISA, and MMP-2 and TIMP-2 mRNA expression levels in peripheral blood mononuclear cells were quantified by qPCR. Between-group differences, transcription–protein coupling, and associations with routine biochemical parameters were analyzed.

Results: Patients with ISR showed increased MMP-2 expression and decreased TIMP-2 expression at both the mRNA and protein levels compared with patients without ISR. The altered MMP-2/TIMP-2 balance was consistent across transcriptional and protein measurements. TIMP-2 showed an inverse association with LDL-C at both levels, whereas the relationships between MMP-2-related measurements and hs-CRP, Hcy, and Lp(a) suggested heterogeneous biochemical regulation. Standardized qPCR- and ELISA-derived measurements showed consistent cross-level patterns, supporting the presence of parallel molecular and protein-level alterations of this axis.

Conclusion: ISR is associated with a consistent peripheral blood MMP-2/TIMP-2 imbalance, involving increased MMP-2 expression and decreased TIMP-2 expression at both the mRNA and circulating protein levels. These findings provide pathobiochemical evidence that matrix-remodeling imbalance in ISR can be reflected in peripheral blood molecular and biochemical profiles.

Keywords

Extracellular matrix
Matrix metalloproteinase-2
Molecular biochemistry
Peripheral blood mononuclear cells
Tissue inhibitor of metalloproteinase-2
Vascular remodeling
DOI: 10.5937/jomb0-67085

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.